The opinion in Puritan
Medical Products Co. v. Copan Italia s.P.a is available here.
(Hat tip to Professor Paul Gugliuzza for noting this case on Twitter; his
article on the subject, Patent Trolls and Preemption, 101 Va. L. Rev.
1579 (2015), is cited in the opinion.) As I note in my recent book Patent
Wars, "since 2013 over thirty state legislatures have enacted laws
forbidding the 'bad faith assertion of patent infringement,'" but
"Federal Circuit case law in recent years has required persons asserting
more traditional unfair competition claims premised on the wrongful assertion
of IP rights" to prove that the claims asserted by the defendant were both
objectively and subjectively baseless; and that if this principle is correct
"the impact of these state laws would appear to be rather
limited." Now the Maine Supreme Judicial Court has held that the
claim asserted in this case was preempted by federal patent law, because the
plaintiff did not prove by clear and convincing evidence that the defendant's
assertion was objectively baseless. For his part, Professor Gugliuzza
thinks that the Maine court applied the Federal Circuit's case law correcfly,
but that that case law itself is dubious. See Gugliuzza, supra,
at 1584 (arguing that “the Federal Circuit's preemption rule is wrong as a
matter of doctrine, is misguided as a matter of policy, and ignores important
lessons from the history of patent enforcement”).
Also on the topic of patent assertion, the IAM Blog has an interesting story this morning
titled Husband
and Wife Accused of Patent Troll Activity Face Criminal Extortion Charges in
Shanghai. As the author, Jacob Schindler, notes, "As cases
like this come to public attention, it may be that China is headed for a big
public debate over the role of NPEs in its patent system. That could have
a huge impact on almost all global tech companies, as well as local patent
stakeholders in China."
No comments:
Post a Comment